Literature DB >> 811749

The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.

S K Pierce, N R Klinman.   

Abstract

The ability of T cells to enhance the response of syngeneic and allogeneic B cells to thymus-dependent hapten-carrier conjugates was analyzed. This analysis was carried out on individual primary B cells in splenic fragment cultures derived from irradiated reconstituted mice. This system has several advantages: (a) the response of the B cells is entirely dependent on carrier priming of the irradiated recipient; (b) this B-cell response can be quantitated in terms of the number of responding cells; and (c) very small B-cell responses can be readily detected and analyzed. The results indicate that the majority of hapten-specific B cells were stimulated in allogeneic and syngeneic recipients only if these recipients were previously carrier primed. The number of B cells responding in carrier-primed allogeneic recipients was 60-70% of that in syngeneic carrier-primed recipients. The antibody-forming cell clones resulting from B cells stimulated in the allogeneic environment produced small amounts of antibody and antibody solely of the IgM immunoglobulin class, while the larger responses in syngeneic recipients were predominantly IgG1 or IgM plus IgG1. The capacity of collaborative interactions between carrier-primed T cells and primary B cells to yield IgG1 antibody-producing clones was shown to be dependent on syngeny between these cells in the H-2 gene complex. It is concluded that: (a) B cells can be triggered by T-dependent antigens to clone formation through collaboration with T cells which differ at the H-2 complex as long as these T cells recognize the antigen; (b) the immunoglobulin class produced by the progeny of stimulated B cells generally depends on the nature of the stimulatory event rather than the nature of the B cell itself; and (c) stimulation to IgG1 production is dependent on syngeny between the collaborating T and B cells probably within the Ir-1A region. The role of the Ia antigens in the formation of IgG1-producing clones is not yet clear; Ia identity could permit IgG1 production or, conversely, nonidentity of Ia could induce all allogeneic interactions which prohibit IgG1 production.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811749      PMCID: PMC2189964          DOI: 10.1084/jem.142.5.1165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors.

Authors:  A Coutinho; G Möller
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

2.  Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

3.  Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody.

Authors:  H Cosenza; H Köhler
Journal:  Science       Date:  1972-06-02       Impact factor: 47.728

4.  The mechanism of antigenic stimulation of primary and secondary clonal precursor cells.

Authors:  N R Klinman
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

5.  Hapten-specific stimulation of secondary B cells independent of T cells.

Authors:  N R Klinman; R A Doughty
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

6.  Induction of immunological tolerance to a thymus-dependent antigen in the absence of thymus-derived cells.

Authors:  J W Schrader
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

7.  The secondary immune response to a hapten in vitro. Antigen concentration and the carrier effect.

Authors:  N R Klinman
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

8.  Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.

Authors:  D Armerding; D H Sachs; D H Katz
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

9.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

10.  Genetic control of the antibody response to poly-L(Tyr,Glu)-poly-D,L-Ala--poly-L-Lys in C3H--CWB tetraparental mice.

Authors:  K B Bechtol; J H Freed; L A Herzenberg; H O McDevitt
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  26 in total

1.  The acquisition of b-cell competence and diversity.

Authors:  N R Klinman
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

2.  Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice.

Authors:  R Papoian; R Pillarisetty; N Talal
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

3.  Mechanisms of antigen-specific, genetically restricted, T cell-B cell interaction.

Authors:  J A Berzofsky
Journal:  Surv Immunol Res       Date:  1984

4.  Macrophages: modulators of immunity. Parke-Davis Award Lecture.

Authors:  C W Pierce
Journal:  Am J Pathol       Date:  1980-01       Impact factor: 4.307

Review 5.  T cell recognition of antigen in vivo: role of the H-2 complex.

Authors:  J Sprent; R Korngold; K Molnar-Kimber
Journal:  Springer Semin Immunopathol       Date:  1980-08

Review 6.  Surface receptors on lymphoreticular cells: sensory devices for host recognition of foreign antigens and neoplasia.

Authors:  B E Elliott; R S Kerbel; Z A Nagy
Journal:  Can Med Assoc J       Date:  1980-06-21       Impact factor: 8.262

7.  Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.

Authors:  F T Liu; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Antibody-specific immunoregulation.

Authors:  S K Pierce; N R Klinman
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Regulatory idiotypes. T helper cells recognize a shared VH idiotope on phosphorylcholine-specific antibodies.

Authors:  K Gleason; H Köhler
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.